Search research articles
Contact Us
Filters
Showing results (131-140 of 168) with videos related to
Page
of 17
Sort By:
European Journal of Cancer
|
March 1, 1981
Phase II evaluation of chlorozotocin (NSC-178248) in advanced human cancer
R W Talley, M K Samson, R W Brownlee, et al.
Cancer Treatment Reports
|
May 1, 1979
American experience with carminomycin
L H Baker, D H Kessel, R L Comis, et al.
Cancer Treatment Reports
|
January 1, 1976
Phase I clinical trial of combined therapy with vinblastine (NSC-49842), bleomycin (NSC-125066), and cisdichlorodiammineplatinum(II)( NSC-119875)
M K Samson, L H Baker, J M Devos, et al.
Journal of Neurosurgery
|
June 1, 1985
Epidemiological findings in a brain-tumor cluster in western Missouri
R A Morantz, J S Neuberger, L H Baker, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
October 1, 1994
Phase II trial of recombinant human macrophage colony-stimulating factor in metastatic soft tissue sarcoma
F A Momin, M Zalupski, L K Heilbrun, et al.
Cancer
|
April 7, 1998
A Southwest Oncology Group and Cancer and Leukemia Group B phase II study of doxorubicin, dacarbazine, ifosfamide, and mesna in adults with advanced osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma
K Antman, J Crowley, S P Balcerzak, et al.
American Journal of Clinical Oncology
|
October 1, 1986
High-dose mitomycin-C with autologous bone marrow transplantation in patients with refractory malignancies. Influence of dose schedule on pharmacokinetics and nonhematopoietic toxicities
C Karanes, V Ratanatharathorn, R B Schilcher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1987
Randomized comparison of cyclophosphamide, imidazole carboxamide, and adriamycin versus cyclophosphamide and adriamycin in patients with advanced stage malignant mesothelioma: a Sarcoma Intergroup Study
M K Samson, L P Wasser, E C Borden, et al.
Cytometry
|
January 1, 1993
DNA content parameters of paraffin-embedded soft tissue sarcomas: optimization of retrieval technique and comparison to fresh tissue
M M Zalupski, Z Maciorowski, J R Ryan, et al.
Cancer Treatment Reports
|
June 1, 1985
Phase II trial of diaziquone in advanced large bowel carcinoma in previously treated and untreated patients: a Southwest Oncology Group Study
R Shildt, R L Stephens, V P Subramanian, et al.
Page
of 17
Search research articles
Search
Showing results (131-140 of 168) with videos related to
Sort By:
Page
of 17
European Journal of Cancer
|
March 1, 1981
Phase II evaluation of chlorozotocin (NSC-178248) in advanced human cancer
R W Talley, M K Samson, R W Brownlee, et al.
Cancer Treatment Reports
|
May 1, 1979
American experience with carminomycin
L H Baker, D H Kessel, R L Comis, et al.
Cancer Treatment Reports
|
January 1, 1976
Phase I clinical trial of combined therapy with vinblastine (NSC-49842), bleomycin (NSC-125066), and cisdichlorodiammineplatinum(II)( NSC-119875)
M K Samson, L H Baker, J M Devos, et al.
Journal of Neurosurgery
|
June 1, 1985
Epidemiological findings in a brain-tumor cluster in western Missouri
R A Morantz, J S Neuberger, L H Baker, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
October 1, 1994
Phase II trial of recombinant human macrophage colony-stimulating factor in metastatic soft tissue sarcoma
F A Momin, M Zalupski, L K Heilbrun, et al.
Cancer
|
April 7, 1998
A Southwest Oncology Group and Cancer and Leukemia Group B phase II study of doxorubicin, dacarbazine, ifosfamide, and mesna in adults with advanced osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma
K Antman, J Crowley, S P Balcerzak, et al.
American Journal of Clinical Oncology
|
October 1, 1986
High-dose mitomycin-C with autologous bone marrow transplantation in patients with refractory malignancies. Influence of dose schedule on pharmacokinetics and nonhematopoietic toxicities
C Karanes, V Ratanatharathorn, R B Schilcher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1987
Randomized comparison of cyclophosphamide, imidazole carboxamide, and adriamycin versus cyclophosphamide and adriamycin in patients with advanced stage malignant mesothelioma: a Sarcoma Intergroup Study
M K Samson, L P Wasser, E C Borden, et al.
Cytometry
|
January 1, 1993
DNA content parameters of paraffin-embedded soft tissue sarcomas: optimization of retrieval technique and comparison to fresh tissue
M M Zalupski, Z Maciorowski, J R Ryan, et al.
Cancer Treatment Reports
|
June 1, 1985
Phase II trial of diaziquone in advanced large bowel carcinoma in previously treated and untreated patients: a Southwest Oncology Group Study
R Shildt, R L Stephens, V P Subramanian, et al.
Page
of 17